BIOSPECIFICS TECHNOLOGIES CO's ticker is BSTC and the CUSIP is 090931106. A total of 89 filers reported holding BIOSPECIFICS TECHNOLOGIES CO in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $26,000 | -13.3% | 496 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $30,000 | +7.1% | 496 | 0.0% | 0.00% | -50.0% |
| Q1 2020 | $28,000 | 0.0% | 496 | 0.0% | 0.00% | +100.0% |
| Q4 2019 | $28,000 | +3.7% | 496 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $27,000 | -10.0% | 496 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $30,000 | -3.2% | 496 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $31,000 | +3.3% | 496 | 0.0% | 0.00% | -50.0% |
| Q4 2018 | $30,000 | +3.4% | 496 | 0.0% | 0.00% | +100.0% |
| Q3 2018 | $29,000 | +31.8% | 496 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $22,000 | 0.0% | 496 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $22,000 | +4.8% | 496 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $21,000 | -8.7% | 496 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $23,000 | -8.0% | 496 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $25,000 | +38.9% | 496 | +52.1% | 0.00% | 0.0% |
| Q1 2017 | $18,000 | – | 326 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JW Asset Management, LLC | 73,649 | $3,646,000 | 2.32% |
| Stonepine Capital Management, LLC | 59,878 | $2,965,000 | 1.60% |
| NORTHPOINTE CAPITAL LLC | 109,644 | $5,428,000 | 0.57% |
| Elk Creek Partners, LLC | 145,406 | $7,199,000 | 0.47% |
| TFS CAPITAL LLC | 18,208 | $901,000 | 0.35% |
| RICE HALL JAMES & ASSOCIATES, LLC | 161,671 | $8,004,000 | 0.35% |
| Ativo Capital Management LLC | 19,592 | $970,000 | 0.26% |
| Matarin Capital Management, LLC | 57,034 | $2,823,753,000 | 0.26% |
| ISTHMUS PARTNERS, LLC | 16,505 | $817,000 | 0.24% |
| Stanley-Laman Group, Ltd. | 12,546 | $621,000 | 0.17% |